{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:26:06Z","timestamp":1787009166747,"version":"build-2736575974"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Spanish Ministry of Science and Innovation\u2014Instituto de Salud Carlos III and Fondos FEDER","award":["JR22\/00044"],"award-info":[{"award-number":["JR22\/00044"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Critically ill pediatric patients admitted to the pediatric intensive care unit (PICU) are highly vulnerable to infections, including invasive fungal diseases and antifungal agents are frequently prescribed. Little is known about antifungal usage in PICUs across Europe.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multinational 3-month weekly point-prevalence study for measuring antifungal drug use was organized. Eigtheen PICUs (16 hospitals) in 10 countries in the European region participated. All patients hospitalized in the participating PICUs and receiving systemic antifungals were included. Information about ward demographics was collected once; weekly ward and patient data were collected prospectively for the 12-week study period and entered in REDCap database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 18 PICUs, 8 (44%) followed prophylactic practices for targeted group of patients, 7\/18 (39%) had an antifungal stewardship program and the majority (16\/18, 89%) had the capacity of biomarker utilization (16\/16 galactomannan, 13\/16 beta-D-glucan, and 9\/16 pan-fungal PCR). One hundred one courses in equal number of patients were recorded; 14 for patients aged &amp;lt;3\u00a0month, 87 for patients \u22653\u00a0month. Malignancy was the most common underlying condition among patients aged \u22653\u00a0month (29%) followed by surgery\/trauma (25%), whereas all patients &amp;lt;3\u00a0month had undergone a recent surgery. Indication for antifungal prescribing was prophylaxis in 38% and treatment in 62% [empirical (57%), preemptive (13%), and targeted (30%)]. Fluconazole was the most common agent both for prophylaxis and treatment, whereas liposomal amphotericin B was the most frequent agent for targeted treatment. The majority (63%) of patients on prophylaxis were oncology or transplant patients. Common reasons for empirical and targeted treatment were persistent fever\/other signs of infections in high-risk patients (61%) and Candida infections (100%), respectively. For targeted treatment, the most frequent pathogens were Candida albicans (37%) and Candida parapsilosis (32%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Most antifungal prescriptions across European PICUs were for treatment. Fluconazole was the most frequently prescribed antifungal. These surveillance data can guide antifungal stewardship strategies in PICUs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jpids\/piaf081","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T11:53:18Z","timestamp":1757505198000},"source":"Crossref","is-referenced-by-count":3,"title":["Antifungal Prescribing in European Pediatric Intensive Care Units: Results of a Multinational 3-Month Weekly Point-Prevalence Survey"],"prefix":"10.1093","volume":"14","author":[{"given":"Elisavet","family":"Chorafa","sequence":"first","affiliation":[{"name":"Infectious Diseases Unit, 3rd Department of Pediatrics, Aristotle University School of Medicine, Hippokration Hospital , Thessaloniki, 54642 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Iosifidis","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, 3rd Department of Pediatrics, Aristotle University School of Medicine, Hippokration Hospital , Thessaloniki, 54642 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha Abdalla","family":"Alkhaaldi","sequence":"additional","affiliation":[{"name":"Al Qassimi Women\u2019s and Children\u2019s Hospital , Sharjah, 61405 ,","place":["United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Arias","sequence":"additional","affiliation":[{"name":"Hospital 12 de Octubre , Madrid, 28041 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benhur Sirvan","family":"Cetin","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Diseases, Faculty of Medicine, Erciyes University , Kayseri, 38039 ,","place":["T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"De Luca","sequence":"additional","affiliation":[{"name":"Infectious Disease Unit, IRCCS, Bambino Ges\u00f9 Children's Hospital , Rome, 00165 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2822-3527","authenticated-orcid":false,"given":"Marieke","family":"Emonts","sequence":"additional","affiliation":[{"name":"Paediatric Immunology, Department of Infectious Diseases and Allergy, Great North Children\u2019s Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust , Newcastle upon Tyne , NE2 4AA,","place":["United Kingdom"]},{"name":"Translational and Clinical Research Institute, Newcastle University , Newcastle upon Tyne, NE2 4AA ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2871-1747","authenticated-orcid":false,"given":"Laura","family":"Ferreras-Antolin","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases and Immunology Unit, St George\u2019s University Hospitals, NHS Foundation Trust , London, SW17 0QT ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Ghimenton-Walters","sequence":"additional","affiliation":[{"name":"North Tees and Hartlepool NHS Foundation Trust , Hartlepool, TS198PE ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9323-2024","authenticated-orcid":false,"given":"Carlos D","family":"Grasa","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Department, Hospital Universitario La Paz, IdiPAZ. CIBERINFEC , Madrid, 28046 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H","family":"Groll","sequence":"additional","affiliation":[{"name":"Infectious Disease Research Program, Center for Bone Marrow Transplantation, Department of Pediatric Hematology\/Oncology, University Children's Hospital , Muenster, 48149 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Herrera-Castillo","sequence":"additional","affiliation":[{"name":"Pediatric Intensive Care Department, Hospital Gregorio Mara\u00f1\u00f3n , Madrid, 28007 ,","place":["Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM) , Madrid, 28007 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lehrnbecher","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology and Hemostaseology, Department of Pediatrics, Goethe University Frankfurt , Frankfurt\/Main, 60629 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Manzanares","sequence":"additional","affiliation":[{"name":"Hospital 12 de Octubre , Madrid, 28041 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Masjosthusmann","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Department of General Pediatrics, University Children's Hospital Muenster , Muenster , 48149,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Melendo","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases and Inmunodeficiencies Unit, Hospital Universitari Vall d' Hebron , Barcelona, 08023 ,","place":["Spain"]},{"name":"Infection and Immunity in Children, Vall d\u2019 Hebron Research Institute , Barcelona, 08023 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Mendoza-Palomar","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases and Inmunodeficiencies Unit, Hospital Universitari Vall d' Hebron , Barcelona, 08023 ,","place":["Spain"]},{"name":"Infection and Immunity in Children, Vall d\u2019 Hebron Research Institute , Barcelona, 08023 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Paulus","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of Oxford , Oxford, OX1 4BH ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0982-1636","authenticated-orcid":false,"given":"Elena","family":"Rinc\u00f3n-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM) , Madrid, 28007 ,","place":["Spain"]},{"name":"Pediatric Infectious Diseases Unit, Department of Paediatrics, Hospital Gregorio Mara\u00f1\u00f3n , Madrid, 28007 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Romani","sequence":"additional","affiliation":[{"name":"Infectious Disease Unit, IRCCS, Bambino Ges\u00f9 Children's Hospital , Rome, 00165 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sdougka","sequence":"additional","affiliation":[{"name":"Pediatric Intensive Care Unit, Hippokration General Hospital , Thessaloniki, 54642 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Solopova","sequence":"additional","affiliation":[{"name":"Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology , Moscow, 117198 ,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Strenger","sequence":"additional","affiliation":[{"name":"Division of General Paediatrics, Department of Paediatrics and Adolescent Medicine, Medical University Graz , Graz, A-8036 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Tedford","sequence":"additional","affiliation":[{"name":"Children's Health Ireland at Crumlin , Crumlin, D12 N512 ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Tzika","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, 3rd Department of Pediatrics, Aristotle University School of Medicine, Hippokration Hospital , Thessaloniki, 54642 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6586-3358","authenticated-orcid":false,"given":"Adilia","family":"Warris","sequence":"additional","affiliation":[{"name":"Medical Research Council Center for Medical Mycology, Department of Biosciences, Faculty of Health and Life Sciences, University of Exeter , Exeter, EX4 4QD ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borbala","family":"Zsigmond","sequence":"additional","affiliation":[{"name":"Heim Pal Children Hospital , Budapest, 1096 ,","place":["Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0202-364X","authenticated-orcid":false,"given":"Emmanuel","family":"Roilides","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, 3rd Department of Pediatrics, Aristotle University School of Medicine, Hippokration Hospital , Thessaloniki, 54642 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"2025100702063318400_ref1","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1097\/INF.0000000000002394","article-title":"Invasive fungal infections in the pediatric intensive care unit","volume":"38","author":"Mantadakis","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"2025100702063318400_ref2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/jpids\/pix046","article-title":"Epidemiology of invasive fungal disease in children","volume":"6","author":"Pana","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2025100702063318400_ref3","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"2025100702063318400_ref4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/INF.0000000000002530","article-title":"Etiology and outcome of candidemia in neonates and children in Europe: an 11-year multinational retrospective study","volume":"39","author":"Warris","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"2025100702063318400_ref5","doi-asserted-by":"crossref","first-page":"myae097","DOI":"10.1093\/mmy\/myae097","article-title":"Invasive candidiasis in a pediatric tertiary hospital: epidemiology, antifungal susceptibility, and mortality rates","volume":"62","author":"Rodrigues","year":"2024","journal-title":"Med Mycol"},{"key":"2025100702063318400_ref6","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1086\/655698","article-title":"Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention","volume":"51","author":"Zaoutis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2025100702063318400_ref7","first-page":"269","article-title":"Management of invasive fungal infections in the pediatric intensive care unit","volume":"3","author":"Chiotos","year":"2014","journal-title":"J Pediatr Intensive Care"},{"key":"2025100702063318400_ref8","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3855\/jidc.4186","article-title":"Characteristics and risk factors of candidemia in pediatric intensive care unit of a tertiary care children's hospital in Egypt","volume":"8","author":"Hegazi","year":"2014","journal-title":"J Infect Dev Ctries"},{"key":"2025100702063318400_ref9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/INF.0000000000003225","article-title":"Characteristics, risk factors and predictors for candidemia in the pediatric intensive care unit at the University Hospital Centre Zagreb in Croatia: a 9-year retrospective study","volume":"40","author":"Matic","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"2025100702063318400_ref10","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/INF.0000000000002186","article-title":"Invasive candidiasis in pediatric intensive care unit: more challenges","volume":"37","author":"Pana","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"2025100702063318400_ref11","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1007\/s00134-013-3057-y","article-title":"Invasive candidiasis in pediatric intensive care in Greece: a nationwide study","volume":"39","author":"Vogiatzi","year":"2013","journal-title":"Intensive Care Med"},{"key":"2025100702063318400_ref12","first-page":"8469585","article-title":"The role of antifungals in pediatric critical care invasive fungal infections","volume":"22","author":"Kaushik","year":"2018","journal-title":"Crit Care Res Pract"},{"key":"2025100702063318400_ref13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12879-021-05774-9","article-title":"Antifungal stewardship in a tertiary care paediatric hospital: the PROAFUNGI study","volume":"21","author":"Mendoza-Palomar","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2025100702063318400_ref14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-0039-1695061","article-title":"Invasive Candida infections in a pediatric intensive care unit in Turkey: evaluation of an 11-year period","volume":"9","author":"Aslan","year":"2020","journal-title":"J Pediatr Intensive Care"},{"key":"2025100702063318400_ref15","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1097\/INF.0000000000003402","article-title":"Pediatric antifungal prescribing patterns identify significant opportunities to rationalize antifungal use in children","volume":"41","author":"Ferreras-Antol\u00edn","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"2025100702063318400_ref16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jgar.2018.08.007","article-title":"Antifungal consumption, indications and selection of antifungal drugs in paediatric tertiary hospitals in Turkey: results from the first national point prevalence survey","volume":"15","author":"\u00c7a\u011flar","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"key":"2025100702063318400_ref17","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/AAC.04109-14","article-title":"Systemic antifungal prescribing in neonates and children: outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) study","volume":"59","author":"Lestner","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2025100702063318400_ref18","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/INF.0000000000004445","article-title":"Antifungal drug usage in European neonatal units: a multicenter weekly point prevalence study","volume":"43","author":"Chorafa","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"2025100702063318400_ref19","doi-asserted-by":"publisher","first-page":"i37","DOI":"10.1093\/jac\/dkq440","article-title":"Treatment and timing in invasive mould disease","volume":"66","author":"Maertens","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2025100702063318400_ref20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40506-022-00258-z","article-title":"Updates in the pharmacologic prophylaxis and treatment of invasive candidiasis in the pediatric and neonatal intensive care units: updates in the pharmacologic prophylaxis","volume":"14","author":"Fly","year":"2022","journal-title":"Curr Treat Options Infect Dis"},{"key":"2025100702063318400_ref21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/jpids\/piv024","article-title":"Failure to validate a multivariable clinical prediction model to identify pediatric intensive care unit patients at high risk for candidemia","volume":"5","author":"Fisher","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2025100702063318400_ref22","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1097\/INF.0000000000003936","article-title":"Is the ERICAP Candida score useful for the diagnosis of candidemia in a pediatric critical care unit?","volume":"42","author":"Falces-Romero","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"2025100702063318400_ref23","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1097\/INF.0000000000000274","article-title":"Per-species risk factors and predictors of invasive Candida infections in patients admitted to pediatric intensive care units: development of ERICAP scoring systems","volume":"33","author":"Jordan","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"2025100702063318400_ref24","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1093\/jpids\/pix054","article-title":"Role of molecular biomarkers in the diagnosis of invasive fungal diseases in children","volume":"6","author":"Huppler","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2025100702063318400_ref25","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1097\/PCC.0000000000002548","article-title":"Candidemia diagnosis with T2 nuclear magnetic resonance in a PICU: a new approach","volume":"22","author":"Cendejas-Bueno","year":"2021","journal-title":"Pediatr Crit Care Med"},{"key":"2025100702063318400_ref26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/cid\/ciac308","article-title":"Multicenter prospective study of biomarkers for diagnosis of invasive candidiasis in children and adolescents","volume":"75","author":"Fisher","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025100702063318400_ref27","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3390\/jof8121262","article-title":"Serum beta-D-glucan in the diagnosis of invasive fungal disease in neonates, children and adolescents: a critical analysis of current data","volume":"8","author":"Ferreras-Antolin","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2025100702063318400_ref28","article-title":"The role of combined use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis in pediatric intensive care unit","author":"Altintop","year":"2021","journal-title":"Turk J Vasc Surg"},{"key":"2025100702063318400_ref29","doi-asserted-by":"crossref","first-page":"ofad538","DOI":"10.1093\/ofid\/ofad538","article-title":"Stewardship-guided T2Candida testing shortens time to antifungal treatment and reduces antifungal usage among medical intensive care unit patients with septic shock","volume":"10","author":"O'Donnell","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2025100702063318400_ref30","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/01.inf.0000178064.55193.1c","article-title":"Use of antimicrobial agents in United States neonatal and pediatric intensive care patients","volume":"24","author":"Grohskopf","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"2025100702063318400_ref31","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025100702063318400_ref32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1469-0691.12040","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp","volume":"18","author":"Hope","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2025100702063318400_ref33","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3390\/jof10100707","article-title":"Prevalence, species distribution and resistance of candidemia in pediatric and adult patients in a Northeast Italy University Hospital","volume":"10","author":"Meneghello","year":"2024","journal-title":"J Fungi (Basel)"},{"key":"2025100702063318400_ref34","first-page":"CD004920","article-title":"Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients","volume":"2016","author":"Cortegiani","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025100702063318400_ref35","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1093\/infdis\/jiaa394","article-title":"Core Recommendations for Antifungal Stewardship: a statement of the Mycoses Study Group Education and Research Consortium","volume":"222","author":"Johnson","year":"2020","journal-title":"J Infect Dis"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpids\/advance-article-pdf\/doi\/10.1093\/jpids\/piaf081\/64235642\/piaf081.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/14\/10\/piaf081\/64235642\/piaf081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/14\/10\/piaf081\/64235642\/piaf081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T06:06:40Z","timestamp":1759817200000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/doi\/10.1093\/jpids\/piaf081\/8250527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piaf081","relation":{},"ISSN":["2048-7207"],"issn-type":[{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,9,10]]},"article-number":"piaf081"}}